Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
TV-0100
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
TVAX Biomedical
|
| https://www.w3.org/2000/01/rdf-schema#label |
TV-O-100
|
| gptkbp:intendedUse |
immunotherapy
|
| gptkbp:mechanismOfAction |
immunotherapy
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:glioblastoma
multiple sclerosis |
| gptkbp:bfsParent |
gptkb:Kamov_Ka-126
|
| gptkbp:bfsLayer |
7
|